29.45
price up icon2.51%   0.72
after-market 시간 외 거래: 29.56 0.11 +0.37%
loading

Genmab Adr 주식(GMAB)의 최신 뉴스

pulisher
Sep 24, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies - GlobeNewswire Inc.

Sep 24, 2025
pulisher
Sep 24, 2025

Genmab A/S (NASDAQ:GMAB) Hits New 12-Month High Following Analyst Upgrade - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

Genmab A/S (NASDAQ:GMAB) Sets New 52-Week High Following Analyst Upgrade - MarketBeat

Sep 23, 2025
pulisher
Sep 16, 2025

Foresight Group Ltd Liability Partnership Takes Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Vident Advisory LLC Buys Shares of 12,377 Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 16, 2025
pulisher
Sep 15, 2025

Scientech Research LLC Increases Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 15, 2025
pulisher
Sep 11, 2025

Genmab A/S (NASDAQ:GMAB) Hits New 52-Week HighStill a Buy? - MarketBeat

Sep 11, 2025
pulisher
Sep 10, 2025

Northern Trust Corp Raises Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Genmab A/S Sponsored ADR $GMAB Shares Sold by Alliancebernstein L.P. - MarketBeat

Sep 09, 2025
pulisher
Sep 08, 2025

Graham Capital Management L.P. Acquires 16,035 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 08, 2025
pulisher
Sep 05, 2025

Cubist Systematic Strategies LLC Grows Holdings in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 05, 2025
pulisher
Sep 04, 2025

Orbis Allan Gray Ltd Has $111.82 Million Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 04, 2025
pulisher
Sep 03, 2025

Synovus Financial Corp Takes $633,000 Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 03, 2025
pulisher
Sep 02, 2025

Tema Etfs LLC Boosts Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 02, 2025
pulisher
Sep 01, 2025

Cresset Asset Management LLC Has $244,000 Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 01, 2025
pulisher
Aug 27, 2025

Cresset Asset Management LLC Has $244,000 Stock Position in Genmab A/S Sponsored ADR $GMAB - Defense World

Aug 27, 2025
pulisher
Aug 27, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Aug 27, 2025
pulisher
Aug 22, 2025

Genmab A/S (NASDAQ:GMAB) Cut to Hold at Zacks Research - Defense World

Aug 22, 2025
pulisher
Aug 21, 2025

IBD Rating Upgrades: MINISO Group Holding ADR Flashes Improved Technical Strength - inkl

Aug 21, 2025
pulisher
Aug 20, 2025

IBD Rating Upgrades: Genmab ADR Shows Improved Relative Price Strength - Investor's Business Daily

Aug 20, 2025
pulisher
Aug 19, 2025

Biotech Stocks To Watch And Pharma Industry News - Investor's Business Daily

Aug 19, 2025
pulisher
Aug 19, 2025

IBD Rating Upgrades: Applied Indl Techs Shows Improved Relative Price Strength - inkl

Aug 19, 2025
pulisher
Aug 18, 2025

What is HC Wainwright’s Forecast for Genmab A/S Q1 Earnings? - Defense World

Aug 18, 2025
pulisher
Aug 18, 2025

IBD Rating Upgrades: HCA Healthcare Shows Improved Technical Strength - inkl

Aug 18, 2025
pulisher
Aug 15, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by LPL Financial LLC - Defense World

Aug 15, 2025
pulisher
Aug 11, 2025

What is William Blair’s Forecast for Genmab A/S Q3 Earnings? - Defense World

Aug 11, 2025
pulisher
Aug 09, 2025

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade - MSN

Aug 09, 2025
pulisher
Aug 08, 2025

Genmab and BioNTech’s Innovative Cancer Trial: A Market Game Changer? - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

BioNTech and Genmab’s Promising Colorectal Cancer Study: A Potential Game-Changer? - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

GMAB: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com

Aug 07, 2025
pulisher
Aug 07, 2025

Genmab and BioNTech’s Promising Cancer Study: A Potential Game-Changer? - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Genmab and BioNTech’s GEN1042 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Aug 07, 2025
pulisher
Aug 06, 2025

Genmab and BioNTech’s Innovative Cancer Trial: A Potential Game-Changer? - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Genmab and BioNTech SE’s GEN1056 Study: A New Hope for Advanced Solid Tumors - The Globe and Mail

Aug 06, 2025
pulisher
Jul 24, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Stake Lessened by Cerity Partners LLC - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Genmab and BioNTech Launch Promising Study for Advanced Colorectal Cancer Treatment - The Globe and Mail

Jul 24, 2025
pulisher
Jul 23, 2025

Genmab (GMAB) Upgraded to Strong Buy: Here's Why - MSN

Jul 23, 2025
$84.16
price down icon 0.45%
$35.77
price down icon 1.30%
$99.75
price up icon 1.51%
$141.00
price down icon 3.01%
biotechnology ONC
$329.84
price up icon 0.23%
자본화:     |  볼륨(24시간):